Command Palette

Search for a command to run...

Novelix Pharmaceuticals Ltd.
40(+0.00%)
1W: +0.03%

Novelix Pharmaceuticals Key Ratios

Cash Conversion Cycle

Latest:29.1 days

Return on Equity

Latest:-29.6%

Return on Capital Employed

Latest:-28.6%

Dupont Analysis

Analysis Summary

MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022
ROE-3.07%-1.34%-2.41%-42.83%-29.63%
PAT margin-20.91%-40.38%-3.10%-2.45%-3.71%
Asset Turnover0.77x0.73x0.76x0.80x0.94x
Leverage1.21x1.22x1.26x1.33x1.28x

Efficiency Ratios

Analysis Summary

MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022
Inventory Days32.430.630.336.140.8
Receivable Days59.1100.881.953.055.4
Payable Days34.139.259.498.967.0
Cash Conversion Cycle57.492.252.8-9.729.1

Return Ratios

Analysis Summary

MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022
ROE-3.07%-1.34%-2.41%-42.83%-29.63%
ROCE-0.28%0.07%-0.75%-40.13%-28.57%
ROA-2.54%-1.09%-1.91%-32.11%-23.17%

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.